Elon Musk said a third person has received an implant from his brain-computer interface company Neuralink, one of many groups working to connect the nervous system to machines. “We’ve got ... three humans with Neuralinks and all are working well,” he said during a wide-ranging interview at a Las Vegas event streamed on his social media platform X.

Neuralink continues its push in the brain-computer interface space with a third implant, while competitors and researchers accelerate advancements globally.

Neuralink’s three implants are part of its ongoing Prime study, which is evaluating the safety of Neuralink’s brain device in individuals with quadriplegia. In September 2024, the company announced the approval of a second study known as Convoy, which will explore extending its brain device capabilities to control an assistive robotic arm.

Elon Musk announced that Neuralink has implanted its third patient, marking a milestone. The company is upgrading its brain-computer interface and plans to expand trials with 20-30 more implants this year,

A third person received a brain implant from Neuralink. Elon Musk said during an interview that Neuralink wants to implant the experimental devices in more people this year. Two other patients received the brain implants in 2024. A third patient received a brain implant from Neuralink, a neurotechnology company founded by Elon Musk.

Neuralink Corp., founded by Elon Musk, continues to push the boundaries of brain-computer interface technology. The company recently announced that its brain implant device has been successfully implanted in three human patients, with plans for an ambitious rollout of 20 to 30 more implants by 2025.

Elon Musk revealed that Neuralink's brain-computer device has been successfully implanted in a third patient, with plans for 20 to 30 more implants this year. He confirmed that all three implants are working well, sharing the update during a Las Vegas event streamed on his X platform, formerly known as Twitter.

Elon Musk's Neuralink brain implant has been approved by Health Canada for clinical trials in Canada. Dr. Andres Lozano, a neurosurgeon at Toronto Western Hospital, discusses the upcoming clinical trials and how the technology could help people with disabilities due to spinal cord injuries or ALS.